3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Active not recruiting
3
Completed
2
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Conditions
Tuberous Sclerosis
1
Seizures
1
Cancer Pain
1
Behavior
1
Interventions
pembrolizumab
74
Cyclophosphamide
50
Cisplatin
46
Nivolumab
36
Radiotherapy
33
Paclitaxel
33
Carboplatin
31
Gemcitabine
30
Docetaxel
27
Dexamethasone
24
atezolizumab
23
Doxorubicin
21
Bevacizumab
21
Etoposide
20
Blood Specimen Collection
20
Vincristine
18
Magnetic Resonance Spectroscopy
18
Leucovorin
18
Lenalidomide
18
Fluorouracil
18
fludarabine
17
Rituximab
17
Radiosurgery
17
Surveys and Questionnaires
16
Oxaliplatin
16
Cytarabine
16
Radiation
15
Ipilimumab
15
palbociclib
14
durvalumab
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Cannabidiol
×
90 days
×
Clear all
NCT05864846
2026-04-27
EpiCom
Jazz Pharmaceuticals
Phase 4
Completed
79 enrolled
NCT06533657
2026-04-21
UTOPIA-1
ZYUS Life Sciences Inc.
Phase 2
Completed
11 enrolled